Titre:
  • Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group.
Auteur:Paridaens, R.; Dirix, Luc Y; Beex, Louk; Nooij, Marianne; Cameron, David A; Cufer, T; Piccart-Gebhart, Martine; Bogaerts, J; Therasse, P.
Informations sur la publication:Journal of clinical oncology, 26, 30, page (4883-4890)
Statut de publication:Publié, 2008-10
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Aged, 80 and over
Androstadienes -- therapeutic use
Antineoplastic Agents -- therapeutic use
Aromatase Inhibitors -- therapeutic use
Bone Neoplasms -- secondary
Breast Neoplasms -- drug therapy
Disease-Free Survival
Drug Resistance, Neoplasm
Estrogen Antagonists -- therapeutic use
Female
Humans
Lymphatic Metastasis
Middle Aged
Postmenopause
Soft Tissue Neoplasms -- secondary
Tamoxifen -- therapeutic use
Treatment Outcome
Note générale:Clinical Trial, Phase II
Clinical Trial, Phase III
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2007.14.4659
info:pii/JCO.2007.14.4659
info:scp/54449099359
info:pmid/18794551
PMC2652082